# Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal Melanoma

> **NCT05546827** · PHASE2 · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 40 (estimated)

## Conditions studied

- Sinonasal Melanoma
- Anorectal Melanoma

## Interventions

- **PROCEDURE:** Surgical resection

## Key facts

- **NCT ID:** NCT05546827
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-09-23
- **Primary completion:** 2028-07-31
- **Final completion:** 2028-07-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05546827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05546827, "Preoperative Radiotherapy and Immunotherapy for Sinonasal and Anorectal Mucosal Melanoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05546827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*